Finding the junction between claudins and endometrial carcinoma

Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189019. doi: 10.1016/j.bbcan.2023.189019. Epub 2023 Nov 10.

Abstract

Endometrial carcinoma (EC) defines a heterogeneous group of neoplastic diseases originating from the transformation of endometrial cells that constitute the internal lining of the uterus. To date several molecular targets have been analysed to describe the natural course of the disease, claudins being among these. Claudins are the main components of tight junctions (TJs), and their main functions are ascribed to the compartmentalization of tissues and cell-cell communication by means of intracellular ions diffusion: these features are typical of epithelial cells. Their overexpression, mis-localization or loss contribute to the malignancy of EC cells. This review collected all available data regarding the expression, regulation and claudin-related signaling pathways to provide a comprehensive view on the influence of claudin in EC progression. Further, the translational potential of claudin differential expression was explored, indicating that their role in personalized medicine could also contribute to EC therapy besides their employment for diagnosis and prognosis.

Keywords: Cancer; Claudins; Endometrium.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Claudins* / genetics
  • Claudins* / metabolism
  • Endometrial Neoplasms* / genetics
  • Endometrial Neoplasms* / metabolism
  • Endometrial Neoplasms* / pathology
  • Epithelial Cells / metabolism
  • Female
  • Humans
  • Signal Transduction
  • Tight Junctions / metabolism
  • Tight Junctions / pathology

Substances

  • Claudins